Abstract:To summarize the clinical diagnosis and treatment process and genetic test results and characteristics of one child with Angelman syndrome (AS) complicated with oculocutaneous albinism type 2 (OCA2), and to review the literature. "Angelman syndrome" "P gene" and "Oculocutaneous albinism type 2" were used as keywords to search at CNKI, Wanfang, and PubMed databases (from creation to December 2019). Then all the patients were analyzed. The patient in this study was a girl aged 1 year. After birth, she was found to present as white body, yellow hair, and nystagmus. She could raise her head at the age of 2 months and turn over at the age of 7 months. The head circumference was 42 cm and she could not sit alone or speak at present. Trio-based exome sequencing revealed that the patient carried a homozygous mutation of c.168del (p.Gln58ArgfsTer44) in the P gene, and her father was heterozygous and her mother was wild-type. The detection of copy number variation showed deletion on the maternal chromosome at 15q11.2-13.1 region (P gene located in this region) in the patient. Until December 2019, a total of 4 cases in the 4 literature had been reported. Adding our case here, the 5 cases were summarized and found that all the cases showed white skin, golden hair, and shallow iris after birth. Comprehensive developmental delay was found around 6 months of age after birth, and the language remained undeveloped in 2 cases till follow-up into childhood. Seizures occurred in 4 patients. Two cases had ataxia. All the 5 cases had acquired microcephaly. Two cases had a family history of albinism. Electroencephalogram monitoring was completed in 3 cases and the results were abnormal. Genetic tests showed that all the 5 cases had deletion on maternal chromosome at 15q11-13 region. Four cases carried mutation of P gene on paternal chromosome. And 1 case was clinically diagnosed as OCA2 without P gene test. AS combined with OCA2 is relatively rare. OCA2 is easily diagnosed based on the obvious clinical manifestations after birth. When combined with clinical manifestations such as neurodevelopmental delay, it might indicate the possibility of AS that is hardly diagnosed clinically at an early stage. Genetic tests can reveal the cross-genetic phenomenon of AS and OCA2 and the complex of them can be eventually diagnosed.

Concurrent PANK2 and OCA2 variants in a patient with retinal dystrophy, hypopigmented irides and neurodegeneration

Novel compound heterozygous mutations in OCA2 gene associated with non-syndromic oculocutaneous albinism in a Chinese Han patient: a case report

Identification of Novel Variations of Oculocutaneous Albinism Type 2 with Prader–Willi Syndrome/angelman Syndrome in Two Chinese Families

Novel compound heterozygous mutations in the PANK2 gene in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration.

Prenatal diagnosis of oculocutaneous albinism type II and novel mutations in two Chinese families.

Novel compound heterozygous mutations in OCA2 gene were identified in a Chinese family with oculocutaneous albinism

A new type of oculocutaneous albinism with a novel OCA2 mutation

Functional Analysis of Two Mutation Sites in the OCA2 Gene

Prenatal genetic diagnosis of oculocutaneous albinism type Ⅱ through mutation detection combined with SNPs linkage analysis

Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism

NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism

A De Novo Mutation of P Gene Causes Oculocutaneous Albinism Type 2 with Prenatal Diagnosis

[Prenatal Diagnosis of Oculocutaneous Albinism Type II and Discovery of Two Novel Mutations].

[Clinical and Molecular Genetic Analysis of Angelman Syndrome with Oculocutaneous Albinism Type 2: A Case Report and Literature Review].

Prenatal genotyping of four common oculocutaneous albinism genes in 51 Chinese families

Identification of 12 OCA Cases in Chinese Population and Two Novel Variants

Prospective Study of the Phenotypic and Mutational Spectrum of Ocular Albinism and Oculocutaneous Albinism

Comprehensive Analysis of Spectral Distribution of a large cohort of Chinese Patients with Non-syndromic Oculocutaneous Albinism Facilitates Genetic Diagnosis.

A novel mutation on OCA2 gene detection and preimplantationgenetic diagnosis for oculocutaneous albinism type 2 (OCA2)

A Novel P Gene Mutation in a Chinese Family with Oculocutaneous Albinism

P gene mutations associated with oculocutaneous albinism type II (OCA2)